Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Apr 2007 07:01

ViaLogy PLC18 April 2007 Date: 18 April 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy PLC Board Appointment LONDON, April 18, 2007 -- ViaLogy PLC (LSE: VIY), the AIM-quoted technologycompany, today announced the appointment of Mr. Shah Talukder as executivedirector of ViaLogy with immediate effect. In addition to his appointment tothe main Board, Mr Talukder has also been appointed President and ChiefExecutive Officer of ViaLogy's wholly-owned American subsidiary, ViaLogy LLC, ofPasadena, California. Mr. Talukder comes to ViaLogy from Cisco Systems, where he was General Managerof Cisco's Safety, Security and Systems Business Unit (S3BU) where heestablished a start-up culture. Within Cisco he developed the vision,strategy, and road map for the Interoperability and Collaboration System (IPICS)family of products and applications. The system enables personnel within thesame or different agencies to communicate across previously isolated radio, IPand non-IP networks by delivering information to various types of communicationsdevices. These could range from a radio, a telephone, and an IP phone to amobile phone and a computer. At Cisco, Mr. Talukder was also instrumental in working closely with customers,industry and technology leaders, research institutions and sensor vendors todefine a vision and strategy for the Sensor Policy Manager (SPM) as a frameworkfor sensor based rapid detection and response to greatly improve the quality andspeed of information dissemination. "I am very excited at the potential of ViaLogy and I am looking forward toleading and growing the team," said Mr. Talukder. "The breadth of technologiesdeveloped by the company is extremely impressive and has a wide range ofapplications. It has the potential to become a platform for sensor and networksub-system interoperability and provide a service delivery architecture based oncustomer specific needs in such areas as Enterprise Security and Operations,Defence, Connected Real Estate, Oil and Gas, Transportation, Home Land Security,Retail and Healthcare." Mr Talukder added: "Customers and industry at large are looking for scaleablesolutions to sensor based remote monitoring, emissions mitigation, greenenvironment, physical and border security. As an example customers globally,regardless of national boundaries, whom I have met and spoken to are keenlyinterested in enhancing their capabilities to remotely monitor and respond togreenhouse gas, seismic and motion sensors, biological agents or to detectpressure in oil or gas pipelines. They want to provide the appropriateinformation within seconds, based on policy and business rules governing theincident. The information could be send to specific PC laptops, cell phones,PDAs, IP Phones, TV or digital signage etc. and could be in the form ofstandards-based video, voice and sensor data". "We are delighted that Shah Talukder has agreed to join us," said Mr. MichaelKelly, the former banker and venture capitalist who spearheaded the mergerarrangements which gave ViaLogy a public quotation on the AIM last year. "At Cisco, Shah has built, managed, and mentored teams towards industryexcellence through product innovations and delivery of solutions and has createda start-up like culture which is reflected by the wide industry acceptance ofCisco IPICS." Mr. Kelly will remain on the board of ViaLogy PLC as a non-executive director. ViaLogy PLC's Chairman, Mr. Terry Bond, stated: "During the last five yearsViaLogy has successfully developed a range of network-centric, real-time signalprocessing technology platforms for sensor applications. We are now transformingViaLogy into a product and sales centric company. Shah Talukder is the idealperson to scale and develop the vision, strategy and focused execution needed tolead ViaLogy forward". For further information please contact: ViaLogy PLCTerry Bond, Chairman - ViaLogy PLC +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy / Liam O'Donoghue +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.